Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
2
NMPA:1
FDA:1
Drug Approvals
Belumosudil Mesylate Tablets
- Product Name
- ζζ₯ε
- Approval Number
- ε½θ―εεHJ20230095
- Approval Date
- Aug 1, 2023
NMPA
Clinical Trials
No trials found
News
Belumosudil Shows Promise in Treating Heavily Pretreated Chronic Graft-versus-Host Disease
Real-world data shows belumosudil is often used in combination after multiple prior therapies for chronic graft-versus-host disease (cGVHD).